$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
When is filgotinib most effective and how long should it be taken?
2026-02-01 22:25:32
Check Details
Detailed explanation of the indications and types of diseases that can be treated with Ivonib (Tosovo)
2026-02-01 22:25:32
Check Details
How many pills of Mitotane are most suitable and safer to take a day?
2026-02-01 22:25:32
Check Details
Detailed description of domestic price of Pemigatinib and reference cost of drug purchase
2026-02-01 22:25:32
Check Details
Whether Erdafitinib is included in the medical insurance catalog and can it enjoy national reimbursement policies?
2026-02-01 22:25:32
Check Details
Which cancers are included in the indications of Erlotinib (Tarceva) and the main treatment groups are introduced
2026-02-01 22:25:32
Check Details
Is tofacitinib (Shangjie) a hormonal drug and its differences with hormonal therapy?
2026-02-01 22:25:32
Check Details
Is Cycloserine a type of drug that is not recommended to be stopped at will once it is started?
2026-02-01 22:25:32
Check Details
None
2026-02-01 22:25:32
Check Details
Analysis of patients’ real experience feedback and long-term treatment impact after taking ribociclib (Kaillon) for two years
2026-02-01 22:25:32
Check Details
Is Cemiplimab an imported drug and its current status in the domestic supply chain and purchasing channels?
2026-02-01 22:25:32
Check Details
Possible side effects of Daprodustat and key points for long-term safety risk monitoring
2026-02-01 22:25:32
Check Details
1
2
...
2428
2429
2430
2431
2432
2433
2434
...
10213
10214
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
FDA Approves Dual Immunotherapy Combo: Tecvayli + Darzalex Faspro Transforms RRMM Treatment
2
Cabozantinib: Pivotal Advancements and Global Implications in Multi-Cancer Treatment with Multi-Kinase Inhibition
3
Pretomanid for Drug-Resistant TB: Risks and Management of 3-Year Treatment
4
SKYSCRAPER-02C Study: New Hope for Extensive-Stage Small Cell Lung Cancer Treatment
5
LPCAT3: The Key Player in MASH Progression to Hepatocellular Carcinoma
6
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer
7
Venetoclax Therapy Guidelines: Balancing Precision Targeting with Risk Management
8
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
9
A Comprehensive Guide to Benralizumab Adverse Reactions: Prevention and Management
10
Lemborexant: A Dual Orexin Receptor Antagonist Revolutionizing Insomnia Treatment
11
Breztri Aerosphere Approved by US FDA for Maintenance Treatment of Asthma in Patients Aged 12 Years and Older
12
Datopotamab Deruxtecan as First-Line Treatment for Advanced Triple-Negative Breast Cancer: Full Interpretation of the Phase III TROPION-Breast02 Trial